Nestle's health science arm will pay $98 million to increase its stake in Aimmune Therapeutics, which is preparing to submit an FDA filing for its peanut allergy treatment, Reuters reports.
Pharmacy
The American Medical Association adopted a policy at its semiannual meeting Nov. 12 that will allow Americans to purchase medicine from Canada in person to fight escalating prescription drug prices in the U.S.
Walmart, Home Depot and other large U.S. employers are cracking down on drugmakers by offering their own programs to limit the amount patients spend on medication, Reuters reports.
Walgreens is cutting thousands of dollars of bonuses for many store managers and other executives, sources familiar with the matter told the Chicago Tribune.
In the U.S., patients spend more on hospital care and clinical services than they do on prescription drugs, yet pharmaceutical companies often pocket more of the money than in other parts of the industry, including most insurers and health systems.…
Coherus BioSciences plans to price its biosimilar of Amgen's Neulasta, an infection-fighting treatment, at $4,175 per unit, according to Reuters. This is a 33 percent discount off the price of the brand name drug.
Merrimack Pharmaceuticals, a Cambridge, Mass.-based drugmaker, will slash its workforce by 60 percent and end development of its lead cancer drug after disappointing clinical trial results, according to Endpoints News.
Japanese drugmaker Takeda Pharmaceutical is expected to gain European Union antitrust approval for its $62 billion acquisition of Shire, a London-based pharmaceutical company, according to Reuters.
At its semiannual policy meeting this month the American Medical Association will consider endorsing a proposal that will allow Americans to purchase medicine from Canada in person as a solution to lowering prescription drug prices, according to a STAT news…
Janssen Pharmaceuticals, owned by Johnson & Johnson, voluntarily recalled three lots of birth control pills because the medication had incorrect instructions.